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ABSTRACT
The inflammatory cytokines involved in the immune response to chronic periodontal 
disease (CPD) in the context of leprosy reactions (LR) were analyzed in 57 new cases 
of multibacillary leprosy (MBL). They were stratified by the presence of CPD and LR. 
Messenger RNA (mRNA) expression of inflammatory mediators was determined by qRT-PCR 
using skin biopsy and by ELISA using serum samples, maintaining 5% of significance level 
in ANOVA and correlation analyses. Twenty-three (40.4%) patients presented the first LR, 
whereas 22 (45.0%) patients presented CPD. IL-4 and IL-6 serum levels were significantly 
lower in patients with CPD and LR than in patients without CPD but with LR; IFN-γ serum 
levels were higher in patients with CPD and LR than in patients with no CPD and no LR; 
IL-4 serum levels were negatively correlated with TNF-α gene expression, while IL-6 serum 
levels were positively correlated with IFN-γ gene expression, in the skin of subjects with 
CPD and LR. The presence of DPC in individuals with LR immunoregulated IL-6, IFN-γ, 
and IL-4 concentrations. The presence of DPC decreased serum levels of IL-6 and IL-4 in 
reactional individuals. CPD concomitant to LR resulted in increased IFN-γ serum levels.
KEYWORDS: Multibacillary leprosy. Reactions. Odontogenic infections. Cytokines. 
Chronic periodontal diseases.
INTRODUCTION
The leprosy reactions (LR) Type 1 (T1R), reverse reaction and type 2 (T2R) 
and erythema nodosum leprosum (ENH) are the most common clinical forms of 
LR observed in 20–50% of the cases of leprosy. They require immediate treatment 
as they cause disabilities and physical deformities1. 
There are evidences that oral coinfections are among the predisposing factors for 
LR2. However, there are gaps in the literature regarding which types of odontogenic 
infections could influence the occurrence of reactional episodes. 
The chronic periodontal disease has been identified as a risk factor to 
cardiovascular disease, stroke and diabetes by increasing systemic inflammatory 
cytokines, among them IFN-γ, TNF-α, IL-63-6. The periodontium, when affected, 
may persist as a reservoir of bacteria, bacterial products and inflammatory cytokines, 
favoring their interaction with structures or organs distant from the oral cavity. Such 
products and/or mediators may induce or perpetuate systemic effects7,8.
Important pro-inflammatory and anti-inflammatory mediators, such as tumor 
necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-1β, IL-6, IL-4, 
and IL-10 are pathophysiologically interrelated not only in LR but also in chronic 
periodontal disease (CPD)9. 
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Appropriate innate and adaptive immune response 
interactions can influence the clinical outcome of leprosy, 
and recent studies suggest that higher serum IFN-γ 
concentrations are related to the development of leprosy 
reactions in individuals with the multibacillary form10,11. 
Considering the plausibility of the relationship 
between CPD and LR, this study aimed to analyze the 
relationship between inflammatory cytokines involved in 
the immune response to CPD and LR. In terms of practical 
implications, the relationship between CPD and LR could 
lead to prioritized dentistry assistance for leprosy patients, 
consequently reducing the risk of physical disabilities. 
METHODS 
Fifty-seven new cases of leprosy were selected by the 
non-probabilistic sampling of convenience type. All the 
selected subjects were multibacillary (MB) according to 
bacilloscopic examination and were diagnosed as new 
cases by specialized physicians in reference centers from 
three endemic municipalities from Mato Grosso State, 
Brazil, from August the 1st, 2012 to January the 31st, 2014 
(18 months). 
Group I constituted new cases experiencing the first 
onset of LR (n=23); Group II was composed of new 
leprosy cases without LR during their first month of leprosy 
treatment (n=34). They were classified as LR type 1 (T1R) 
or reverse reaction and type 2 (T2R) or erythema nodosum 
leprosum (ENH).
The following patients were excluded from the study: 
those who were being treated for LR, were LR recurrent, 
used other medication for the last 6 months besides the 
multidrug therapy (WHO/MDT), or who presented any 
comorbidity during medical evaluation.
Data related to dental and gingival-periodontal 
conditions were collected at the first dental appointment in 
a specialized dentistry center. CPD was defined in patients 
who presented at least one (1) site with clinical insertion 
loss equal to 3 mm and probing depth equal to 4 mm12.
Blood, skin and gum tissues were collected. Blood 
samples collection and skin biopsy were performed on the 
day of leprosy diagnosis or the first LR. 
Blood samples (10 mL) were obtained by venous 
puncture and collected in a vacuum tube containing 
a coagulation inhibitor for the serological analysis of 
inflammatory cytokines, such as TNF-α, IFN-γ, IL-1β, 
IL-6, IL-4, IL-10 and IL-12p70. After collection, the tubes 
were placed in an upright position at room temperature 
for clot retraction (approximately 60 min) and centrifuged 
(400 x g for 10 min). The obtained serum (2 mL) was stored 
in cryogenic tubes at -80 °C. 
Qualified professionals performed punch skin biopsy 
of 5.0 mm diameter of tissue from the edge of the lesion. 
The gingival tissue biopsy was performed 7 and 14 d after 
blood collection and skin biopsy. The site for the gingival 
tissue collection represented the worst clinical condition 
after performing the periodontal clinical examination. 
The anatomical region adjacent to the dental element, 
i.e., the interproximal wedge, was used for removal of the 
gingival tissue. In case of patients who needed to undergo 
dental extraction or cystic removal, the biopsy sample was 
collected at the time of the surgical procedure.
RNA from the skin and gingival tissue samples was stored 
in a cryogenic tube and frozen at -80 °C prior to analysis of 
gene expression of inflammatory cytokines, TNF-α, IFN-γ, 
IL-1β, IL-6, IL-4, IL-10 and IL-12p70. Quantitative reverse 
transcription- polymerase chain reaction (qRT-PCR) was 
performed for mRNA analysis. Total RNA extraction was 
performed using TRIzol (Thermo Fisher Scientific, Carlsbad, 
CA, USA), according to the manufacturer’s protocol. The 
yield and purity of extracted RNA were evaluated using the 
NanoDrop spectrophotometer (Thermo Fisher Scientific, 
Carlsbad, CA, USA). Samples with appropriate quantities 
of RNA, above 100 ng/µL, and purity between 1.7 and 
1.9 were considered for further analysis. The cDNA synthesis 
was performed from 1 µg of mRNA with SuperScript III 
(Invitrogen, Carlsbad, CA, USA), according to the 
manufacturer’s instruction. Gene expression was calculated 
by the relative standard curve method using the GAPDH gene 
expression as the endogenous control. Quantification of the 
target gene and the GAPDH gene expression was obtained 
from their Ct (threshold cycle) on the standard curve. Thus, 
the relative expression was calculated normalizing the target 
data by the GAPDH data in each sample.
The qPCR reactions were performed using TaqMan 
Gene Expression Assays (Applied Biosystems, Foster 
City, CA, USA), according to the manufacturer’s 
recommendations in a StepOne Plus real-time PCR 
equipment (Applied Biosystems, Foster City, CA, USA). 
Serum levels of inflammatory cytokines was measured by 
ELISA, using a Quantikine® ELISA Kit (R&D Systems, 
Minneapolis, MN 55413, USA) and a microplate reader 
(MultiSkan FC; ThermoScientific®) at 450 nm or 490 nm, 
according to the manufacturer’s protocol, specific for each 
investigated cytokine. 
The Spearman correlation coefficient was used for 
exploratory analysis. Data of the mediators resulting from 
blood samples and biopsies were evaluated regarding 
the distribution of normality by the Shapiro-Wilk test, 
normalized by a logarithmic function. The Student’s 
t-test was performed to determine differences between 
mean values, and the analysis of variance (ANOVA) 
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was carried out in case of variables with more than two 
comparison groups using the Prism software version 5, at 
5% significance level.
Ethical considerations
This research was approved by the Ethics Committee in 
Research of the Hospital Universitario Julio Müller of the 
Federal University Foundation of Mato Grosso, Protocol 
Nº 930/CEP-HUJU/2010. After explaining the purpose, 
procedure and importance of the study, written informed 
consent was obtained from all patients examined. For 
participants under the age of 18 years written informed 
consent was systematically obtained from the family heads 
or guardians. All study participants received instructions on 
oral hygiene, prevention of caries and periodontal disease. 
When necessary, they underwent dental and surgical 
treatment.
RESULTS
From the total of 57 multibacillary subjects studied, 
23 (40.4%) new cases were evaluated to have their first 
LR, of which 5 (21.7%) presented T1R and 18 (78.3%) 
presented T2R; 34 (59,6%) were new cases without LR; 
22 (45.0%) patients presented CPD; 34 were (59.6%) 
male patients; the average age of the study group was 
40.0 years (male: SD = ±18.2; female: SD = ±20.63); 
29 (50.9%) patients declared themselves as African 
descendants; 28 (49.1%) attended high school or had a 
college degree; 47 (82.5%) lived in urban areas; 41 (71.9%) 
reported a family income inferior or equal to 2 minimum 
wages (US$ 602). Considering the clinical characteristics, 
25 (43.9%) were BT; 10 (17.5%) BB; 5 (8.8%) BV and 
17 (29.8%) were virchowian13; 31 (53.6%) patients showed 
no neural impairment, 24 (46.2%) had grade 1 physical 
disability, and none of the patients had grade 2 physical 
disability.
Results of the relative mRNA expression analysis of 
IFN-γ, TNF-α, IL-10, IL-6 and IL-1β from the skin biopsies 
of MB patients revealed a higher than average expression of 
IL-6, IFN-γ and IL-1β; in gingival tissue biopsies of subjects 
with gingival-periodontal impairment, mRNA expression 
of IFN-γ and IL-1β reached higher than average values. In 
serum samples, the level of the mediator IL-6 was found to 
be the highest, followed by IL- 10 and TNF- α (Table 1). 
Table 1 - Descriptive analysis of inflammatory mediators in the skin and gingiva of multibacillary leprosy cases according to variables 
related to gene expression and serum quantitation (pg/mL)
Inflammatory mediators n Minimum Maximum Mean SDc
Gene expression of inflammatory mediators
Skin biopsy
IFN-γ 26 0.127 185.800a 16.560 42.320
TNF-α 17 0.384 33.751 3.816 7.938
IL-10 20 0.451 32.724 7.480 10.418
IL-6 20 0.053 1143.542 58.653 255.384
IL-1β 22 0.023 288.852 13.453 61.513
 Gingival tissue biopsy
IFN-γ 7 0.011 416.801 60.118 157.284
TNF-α 7 0.079 0.800 0.307 0.265
IL-10 8 0.067 2.763 1.155 1.076
IL-6 9 0.014 5.940 1.158 1.936
IL-1β 9 0.052 19.867 3.737 6.318
Inflammatory mediators in serum (pg/mL)
IFN-γ 16 0.001 0.088 0.013 0.021
TNF-α 26 0.002 0.135 0.018 0.027
IL-10 34 0.001 0.105 0.020 0.026
IL-6 51 0.003 0.651b 0.078 0.120
IL-4 29 0.001 0.005 0.002 0.001
IL-12p70 33 0.001 0.014 0.003 0.003
a,boutliers (a = 10779.85; b = 3025.98); cSD= standard deviation
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In skin biopsies, IL-4 and IL-12p70 were not detected. 
In case of patients with CPD and LR, there was a negative 
correlation between serum IL-4 and TNF-α expressed in 
the skin (r = 0.83; p < 0.05); a positive correlation between 
IL-4 and IFN-γ present in serum (r = 0.89; p < 0.05) and 
between serum IL-6 and IFN-γ expressed in the skin 
(r = 0.79; p < 0.05) (Table 2). 
Higher concentrations of IL-6 were found in serum 
samples of patients with LR (p = 0.036). There was no 
significant difference in the expression of IFN-γ, TNF-α, 
IL-10, IL-6 and IL-1β in the skin and results found the 
gingiva biopsies of patients with and without LR, even 
though the gene expression in skin biopsies was observed 
among the cases with LR. In case of gingiva, only IL-1β 
gene expression was high (Table 3).
Patients with CPD and LR presented higher IL-1β gene 
expression in skin than those without CPD (p = 0.007) 
(Table 3). No statistically significant difference was 
observed for other mediators (Table 4).
In patients with CPDLR, serum levels of IL-4 were 
significantly lower than those in patients with no CPDLR. 
On the contrary, these cases showed higher levels of IL-4 
than patients with no CPD and no LR (Figure 1A).
Levels of IL-6 in patients with CPDLR were significantly 
lower than those in patients with no CPDLR (Figure 1B). 
In contrast, the levels of IL-6 in patients with no CPDLR 
were higher than those in patients with no CPD and no LR 
(Figure 1B).
Serum levels of IFN-γ in patients with CPDLR were 
significantly higher than those in patients with no CPD and 
no LR. However, no significant difference in serum levels 
of TNF-α was found among the groups (Figure 2B).
DISCUSSION
Accumulating evidence suggests the involvement of 
similar inflammatory cytokines in the development of PD 
and of LR9, and in this study, it was demonstrated that 
patients with CPD have a modified serum profile of IL-4, 
IL-6 and IFN-γ.
It is known that CD8+ cells, along with Th2 cells, 
produce predominantly IL-4. IL-4 has an antagonistic effect 
on IFN-γ and its main activity is to suppress the immune 
response mediated by cells owing to no optimization 
of TLR1 activation, as well as downregulation of the 
expression of these receptors on the surface of monocytes14. 
Contrary to the action mechanism of IL-4 on the cell 
activity, IL-6, IFN-γ and TNF-α promote the activation of 
the immune response mediated by Th1 cells15.
In this study, IL-4 detected in serum samples showed 
a negative correlation with TNF-α gene expression in skin 
biopsies of patients with CPDLR. Additionally, low and 
significant levels of IL-4 were found in serum samples 
of patients with CPDLR as compared to those in patients 
without PD, and higher levels of IFN-γ were observed in 
serum samples of patients with CPDLR than in serum 
samples of patients with no CPD and no LR. These 
results suggest an immunoregulatory role of PD in these 
conditions and a possibility of Th1 cell-mediated activation 
of mediators in the skin, which would be consistent with 
Table 2 - Spearman correlation coefficient between inflammatory mediators (IFN-γ, TNF-α, IL-10, IL-6, IL-4 and IL-12p70) in the 
skin and those in serum samples of multibacillary leprosy cases with chronic periodontal disease and leprosy reaction
Skin biopsy Serum
IFN-γ TNF-α IL-10 IL-6 IL-1β IFN-γ TNF-α IL-10 IL-6 IL-4 IL-12p70
Skin
IFN-γ 1
TNF-α 0.60 1
IL-10 0.68 0.66 1
IL-6 0.60 0.50 0.30 1
IL-1β 0.00 0.20 0.49 1
Serum
IFN-γ 0.10 0.00 -0.50 -0.10 1
TNF-α 0.80 -0.50 0.40 0.20 0.56 1
IL-10 -0.30 0.40 0.60 0.76 0.95 1
IL-6 0.79* -0.20 0.36 0.40 0.04 0.61 0.50 -0.03 1
IL-4 0.00 -0.83* -0.41 0.00 0.00 0.89* 0.63 0.34 0.55 1
IL-12p70 0.80 0.60 -0.40 0.50 0.20 0.40 0.30 0.45 1
*p-value ≤ 0.05
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fostering of LR and impairment of the patient’s general 
condition16. 
Santos et al.10 observed that reactional multibacillary 
patients presented highest concentrations of serum IFN-γ. 
Likewise, Motta et al.17 observed that the odontogenic 
infection in subjects with leprosy could increase the 
pro-inflammatory response mediated by IFN-γ, while the 
contrasting effect would occur on the immunoregulatory 
activity of IL-4, triggering exacerbation of the inflammatory 
reaction.
Table 3 - Descriptive analysis of inflammatory mediators in the skin, gingiva and serum samples in cases of multibacillary leprosy 
according to leprosy reactions (Yes/No)
Inflammatory 
mediators
Leprosy 
reactions N Mean
IC* (95%)
F** p-value
Inferior Superior
Skin
IFN-γ Yes 13 3.808 1.040 13.736 0.063 0.804
No 13 2.981 0.554 15.959
TNF-α Yes 8 2.059 0.726 5.870 0.645 0.434
No 9 1.305 0.571 3.004
IL-10 Yes 10 3.390 1.336 8.499 0.031 0.861
No 10 3.046 1.105 8.331
IL-6 Yes 8 1.789 0.139 22.874 3.331 0.085
No 12 0.290 0.122 0.691
IL-1β Yes 10 0.485 0.083 2.829 2.314 0.144
No 12 0.142 0.083 0.307
Gingival tissue
IFN-γ Yes 5 0.297 0.024 3.633 1.734 0.245
No 2 8.577 0.000 2.3e+22
TNF-α Yes 6 0.199 0.085 0.468 1.209 0.322
No 1 0.519 - -
IL-10 Yes 6 0.570 0.092 3.525 0.004 0.949
No 2 0.622 0.002 228.149
IL-6 Yes 7 0.467 0.071 3.096 1.251 0.300
No 2 2.578 0.038 177.683
IL-1β Yes 7 1.379 0.239 7.925 0.016 0.904
No 2 1.154 0.021 64.715
Serum (pg/mL)
IFN-γ Yes 10 0.008 0.003 0.024 4.125 0.062
No 6 0.002 0.001 0.004
TNF-α Yes 12 0.012 0.007 0.020 0.371 0.548
No 14 0.009 0.005 0.018
IL-10 Yes 15 0.010 0.005 0.022 0.006 0.939
No 19 0.010 0.006 0.017
IL-6 Yes 20 0.082 0.022 0.304 4.668 0.036
No 31 0.023 0.014 0.038
IL-4 Yes 12 0.002 0.001 0.003 1.547 0.224
No 17 0.001 0.001 0.002
IL-12p7 Yes 13 0.003 0.002 0.005 1.271 0.268
No 20 0.002 0.002 0.003
*IC (95%) (95% confidence interval); **F (F test)
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Both, LR and PD, independently present a complex 
network of immune activity that culminates with the 
participation of various cell types and inflammatory 
cytokines, both in serum samples and tissues affected by 
the disease9. 
The coexistence of infections, such as leprosy and 
Figure 1 - Comparison between serum levels of (A) IL-4 and (B) IL-6 among patients with CPD and those with no CPD with LR 
and no LR. Mann-Whitney test; 5% significance level. CPDLR (chronic periodontal disease and leprosy reaction); NCPDLR (no 
chronic periodontal disease and leprosy reaction); CPDNLR (chronic periodontal disease and no leprosy reaction); NCDPNLR (no 
chronic periodontal disease and no leprosy reaction).
Table 4 - Descriptive analysis of inflammatory mediators in the skin and gingiva of multibacillary leprosy cases with leprosy reaction 
in the presence of chronic periodontal disease (CPD: Yes/No)
Inflammatory 
mediators CPD n Mean
IC (95%)
F** p-value
Inferior Superior
Skin
IFN-γ Yes 8 5.002 0.878 28.789 0.205 0.661
No 3 2.484 0.001 3395.799
TNF-α Yes 6 2.270 0.497 10.381 0.240 0.645
No 1 1.051 - -
IL-10 Yes 7 3.221 1.116 9.300 0.287 0.609
No 2 5.870 2.2e-9 1.5e+10
IL-6 Yes 5 0.664 0.053 8.331 3.305 0.129
No 2 43.380 4.3e-17 4.4e+19
IL-1β Yes 7 0.232 0.120 0.445 13.895 0.007
No 2 1.3e-13 1.4e-13 3.6e+15
Gingival tissue
TNF-α Yes 4 0.139 0.063 0.307 3.799 0.123
No 2 0.415 0.000 2275.602
IL-10 Yes 4 0.407 0.015 10.805 0.407 0.558
No 2 1.127 0.000 7942.632
IL-6 Yes 5 0.343 0.018 6.488 0.361 0.574
No 2 1.010 0.000 4865.866
IL-1β Yes 5 1.076 0.073 15.959 0.262 0.630
No 2 2.563 0.000 2.2e+4
*IC (95%) (95% confidence interval); **F (F test)
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PD, promotes a change in the pattern of inflammatory 
response by either activating, inhibiting, or enhancing these 
processes2,17,18. The same systemic condition was observed 
in diabetes and PD19.
The balance between Th1 and Th2 cells and a change in 
the mediator profile found in serum samples and of those 
expressed in skin, such as IFN-γ, TNF-α, IL-1β, IL-6 and 
IL-4, both during the occurrence of T1R and T2R, seems to 
be closely related to the clinical spectrum of the disease. In 
PD, although there is no consensus on the immunological 
standards involved in the pathophysiology, a combined 
function of Th1 and Th2 cells is possible20. 
The complex association between the inflammatory 
cytokines and the immune cells system during LR and CPD 
manifestation has prompted researchers to conduct more 
specific studies on the cell type and cytokine determinants 
of these processes9, as well as on other cell types, such as 
keratinocytes and fibroblasts, as well as cytokine producers 
in response to bacterial stimulation or other cytokines16,21.
Particularly in the case of leprosy, in patients with 
borderline clinical features, the participation of other cell 
subtypes, such as the subpopulations of Th0 cells that 
seem to produce both IFN-γ and IL-4 in occurrence of 
T1R has been described. However, Th1 polarization along 
with IFN-γ production could also occur in the face of T1R 
recurrence22. Other cell subtypes, such as the regulatory 
T cells (Tregs), Th3 cells with an immunosuppressive 
profile and Th17 cells with a pro-inflammatory profile, may 
participate in the determination of the cell profile and the 
involved mediators23,24. However, the understanding of the 
association between molecular and cellular paths and the 
pathogenesis of CPD and LR is still incomplete.
Considering the involvement of IL-6 in the development 
of LR, the results of this study are consistent with those 
in the literature, in which patients with LR showed higher 
levels of IL-6 in serum samples than the levels in patients 
with no LR. Recognized as a potential inflammatory 
marker of LR, IL-6 stands out due to its multifunctional 
profile9,18,25. 
In case of patients with CPD and reactional states, 
a positive correlation between IL-6 in the serum and 
IFN-γ gene expression in the skin was found. Therefore, 
an increased serum level of IL-6 may contribute to an 
increase in gene expression of IFN-γ in the skin, which 
could justify the intensification of Th1 type cell response 
with triggering or maintenance of the LR. However, 
in case of patients with CPD or reactional episodes, 
the serum level of IL-6 was lower than that in patients 
without CPD and reactional episodes, suggesting an IL-6 
downregulation in the presence of PD. On the contrary, as 
described previously, other cell types, such as Th0 cells, 
Tregs, and keratinocytes, may influence the inflammatory 
mechanisms.
The influence of PD on the manifestation of LR was 
strengthened by the clinical improvement of reactional 
symptoms after subjects with odontogenic infections and 
LR received dental treatment18. Additionally, the probability 
of occurrence of LR may increase when the patient presents 
poor oral health26. 
It was not possible to verify significance values of 
gene expression of mediators in the gingival tissue related 
to the presence of CPD and LR. This fact may have been 
influenced by the difficulty in participants’ allocation, since 
the patients had already begun treatment for LR when the 
Figure 2 - Comparison between serum levels of (A) IFN-γ and (B) TNF-α among patients with CPD and no CPD and with LR and 
no LR. Mann-Whitney test; 5% significance level. CPDLR (chronic periodontal disease and leprosy reaction); NCPDLR (no chronic 
periodontal disease and leprosy reaction); CPDNLR (chronic periodontal disease and no leprosy reaction); NCDPNLR (no chronic 
periodontal disease and no leprosy reaction).
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biopsy was performed, or even due to the sample size. 
Although this represents a study limitation, it should be 
emphasized that blood collection was performed on the 
same day of skin biopsy, before initiation of the reactional 
treatment, and in the initial weeks of leprosy treatment.
Considering the gingival tissue, IFN-γ and IL-1β 
showed higher mean values for gene expression, although 
not statistically significant, than that of other mediators 
studied. This is in agreement with the literature, since both 
IFN-γ and IL-1β are important mediators involved in bone 
resorption during the development of PD and the extent 
and severity of these diseases9. It is possible that treatment 
of reactional episodes or even polychemotherapy, favor the 
reduction of pathogenic microorganisms responsible for the 
development of CPD, and consequently, the expression of 
inflammatory cytokines in the gingiva. More specific studies 
are necessary to clarify this approach.
As an original study on CPD and LR, it could be stated 
that the results suggested an interaction between CPD and 
immunoregulatory mechanisms involved in the triggering, 
exacerbation and maintenance of LR. These interactions can 
promote the expression of TNF-α and IFN-γ in the skin, 
while downregulating IL-4 and IL-6 in the serum. 
Considering the previous approaches, questions about 
the association between molecular and cellular paths and 
the pathogenesis of these diseases suggest the need of future 
investigations.
CONCLUSION 
The presence of DPC in individuals with LR 
immunoregulated the concentrations of IL-6, IFN-γ and 
IL-4. The presence of DPC decreased serum levels of IL-6 
and IL-4 in reactional individuals. CPD concomitant to LR 
resulted in increased IFN-γ serum levels.
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